113 related articles for article (PubMed ID: 19879234)
1. Innate immune defense in visceral leishmaniasis: cytokine mediated protective role by allogeneic effector cell.
Manna PP; Chakrabarti G; Bandyopadhyay S
Vaccine; 2010 Jan; 28(3):803-10. PubMed ID: 19879234
[TBL] [Abstract][Full Text] [Related]
2. Cellular therapy by allogeneic macrophages against visceral leishmaniasis: role of TNF-α.
Manna PP; Hira SK; Basu A; Bandyopadhyay S
Cell Immunol; 2014 Jul; 290(1):152-63. PubMed ID: 24996013
[TBL] [Abstract][Full Text] [Related]
3. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
Engwerda CR; Smelt SC; Kaye PM
Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
[TBL] [Abstract][Full Text] [Related]
4. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
Datta N; Mukherjee S; Das L; Das PK
Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
[TBL] [Abstract][Full Text] [Related]
5. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
Holaday B; Sadick MD; Pearson RD
J Immunol; 1988 Sep; 141(6):2132-7. PubMed ID: 3262649
[TBL] [Abstract][Full Text] [Related]
6. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
Sarkar K; Das PK
J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
[TBL] [Abstract][Full Text] [Related]
8. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.
Murray HW; Stern JJ; Welte K; Rubin BY; Carriero SM; Nathan CF
J Immunol; 1987 Apr; 138(7):2290-7. PubMed ID: 3104456
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells.
Vosskuhl K; Greten TF; Manns MP; Korangy F; Wedemeyer J
J Immunol; 2010 Jul; 185(1):119-25. PubMed ID: 20511546
[TBL] [Abstract][Full Text] [Related]
10. Involvement of membrane-associated TNF in the killing of Leishmania donovani parasites by macrophages.
Lohmann-Matthes ML; Lüttig B; Hockertz S
Behring Inst Mitt; 1991 Feb; (88):125-32. PubMed ID: 2049029
[TBL] [Abstract][Full Text] [Related]
11. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C
J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237
[TBL] [Abstract][Full Text] [Related]
12. Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
Bhaumik SK; Paul J; Naskar K; Karmakar S; De T
J Antimicrob Chemother; 2012 Apr; 67(4):910-20. PubMed ID: 22258930
[TBL] [Abstract][Full Text] [Related]
13. Functional heterogeneity of macrophage precursor cells from spleen of Leishmania donovani-infected and untreated mice.
Hockertz S; Baccarini M; Lohmann-Matthes ML
J Immunol; 1989 Apr; 142(7):2489-94. PubMed ID: 2926141
[TBL] [Abstract][Full Text] [Related]
14. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
15. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
Bohn E; Autenrieth IB
J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection.
Aranha FC; Ribeiro U; Basse P; Corbett CE; Laurenti MD
Scand J Immunol; 2005 Oct; 62(4):334-41. PubMed ID: 16253120
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cells participate in the early defense against Leishmania major infection in mice.
Laskay T; Röllinghoff M; Solbach W
Eur J Immunol; 1993 Sep; 23(9):2237-41. PubMed ID: 8370404
[TBL] [Abstract][Full Text] [Related]
18. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
Sadick MD; Locksley RM; Tubbs C; Raff HV
J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
[TBL] [Abstract][Full Text] [Related]
19. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
Sypek JP; Panosian CB; Wyler DJ
J Immunol; 1984 Dec; 133(6):3351-7. PubMed ID: 6333458
[TBL] [Abstract][Full Text] [Related]
20. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]